Ultragenyx Pharmaceutical Inc. (RARE) stock prices updated...
 

Ultragenyx Pharmaceutical Inc. stock price

Ultragenyx Pharmaceutical Inc. latest news:


  • 01/10/2018 15:02:06

    BRIEF-Capital International Investors Reports 10.3 Pct Passive Stake In Ultragenyx

    Ultragenyx Pharmaceutical Inc(RARE): * CAPITAL INTERNATIONAL INVESTORS REPORTS 10.3 PERCENT PASSIVE STAKE IN ULTRAGENYX PHARMACEUTICAL INC AS OF DECEMBER 29, 2017 - SEC FILING‍​ Source text for Eikon: Further company coverage:

  • 11/15/2017 11:30:54

    BRIEF-ULTRAGENYX SAYS FDA APPROVES MEPSEVII FOR GENETIC DISEASE MUCOPOLYSACCHARIDOSIS VII

    Ultragenyx Pharmaceutical Inc(RARE): * ULTRAGENYX ANNOUNCES FDA APPROVAL OF MEPSEVII™, THE FIRST THERAPY FOR PROGRESSIVE AND DEBILITATING RARE GENETIC DISEASE MUCOPOLYSACCHARIDOSIS VII.

  • 11/15/2017 10:35:57

    UPDATE 1-U.S. FDA approves Ultragenyx drug for rare enzyme disorder

    Nov 15 (Reuters) - The U.S. Food and Drug Administration approved on Wednesday a new treatment made by Ultragenyx Pharmaceutical Inc for a rare genetic disorder that can dramatically reduce life expectancy.

  • More trends:

    Ultralife CorporationULBI | Ultrapetrol (Bahamas) LimitedULTR | Ultratech, Inc.UTEK | UMB Financial CorporationUMBF | Umpqua Holdings CorporationUMPQ | Unico American CorporationUNAM | Unilife CorporationUNIS | Union Bankshares CorporationUBSH | Union Bankshares, Inc.UNB | Uni-Pixel, Inc.UNXL |